An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult Still's Disease
- Conditions
- Still's Disease Adult Onset
- Interventions
- First Posted Date
- 2024-07-11
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 148
- Registration Number
- NCT06497491
- Locations
- 🇷🇺
State budgetary healthcare institution "Chelyabinsk Regional Clinical Hospital", Chelyabinsk, Chelyabinsk region, Russian Federation
🇷🇺Limited Liability Company "Medical Center "Revma-Med", Kemerovo, Russian Federation
🇷🇺Limited Liability Company "OLLA-MED", Moscow, Russian Federation
A Study of Genolair in Two Dosage Forms (Solution and Lyophilisate) and Xolair® in Healthy Volunteers
- Conditions
- Allergic Asthma
- Interventions
- Biological: Genolair, lyophilisate for the preparation of solution for subcutaneous administrationBiological: Genolair, solution for subcutaneous administration, 150 mgBiological: Xolair®, solution for subcutaneous administration, 150 mg
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 180
- Registration Number
- NCT06494345
- Locations
- 🇷🇺
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department", Moscow, Russian Federation
An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis
- Conditions
- Plaque Psoriasis
- Interventions
- Biological: GNR-068Biological: Stelara®
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 422
- Registration Number
- NCT06488664
- Locations
- 🇷🇺
Limited Liability Company "Available Polyclinic", Murino, Leningrad Region, Russian Federation
🇷🇺Limited Liability Company "Family Clinic No. 4", Korolev, Moscow Region, Russian Federation
🇷🇺Limited Liability Company Medical Center "Azbuka Health", Kazan, Republic Of Tatarstan, Russian Federation
A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers
- Conditions
- Healthy Volunteers
- Interventions
- Biological: Actemra®Biological: Complarate
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 256
- Registration Number
- NCT06488521
- Locations
- 🇷🇺
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department", Moscow, Russian Federation
🇷🇺Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov Ministry of Health of Russia, Moscow, Russian Federation
🇷🇺LLC "X Seven Clinical Research", Saint Petersburg, Russian Federation
A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers
- Conditions
- Healthy Volunteers
- Interventions
- Biological: Complarate®Biological: Actemra®
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 43
- Registration Number
- NCT06481202
- Locations
- 🇷🇺
Department of Clinical Research, Center for Clinical Drug Research, Moscow, Russian Federation
🇷🇺Federal State Autonomous Educational Institution of Higher Education "First Moscow State Medical University named after I.M. Sechenov" of the Ministry of Health of Russia, Moscow, Russian Federation
A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers
- Conditions
- Healthy Volunteers
- Interventions
- Biological: GNR-068Biological: Stelara®
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 122
- Registration Number
- NCT06481215
- Locations
- 🇷🇺
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department", Moscow, Russian Federation
🇷🇺Federal State Budgetary Educational Institution of Higher Education "Moscow State Medical and Dental University named after A.I. Evdokimov" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
A Safety, Pharmacokinetics and Pharmacodynamics Study of GNR-086 and Ilaris® in Healthy Volunteers
- Conditions
- Healthy Volunteers
- Interventions
- Biological: GNR-086Biological: Ilaris®
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 105
- Registration Number
- NCT06481189
- Locations
- 🇷🇺
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department", Moscow, Russian Federation
🇷🇺Federal State Budgetary Educational Institution of Higher Education "Moscow State Medical and Dental University named after A.I. Evdokimov" of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
Comparison of Complarate® (Tocilizumab Biosimilar) and Actemra® in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- Interventions
- Biological: Complarate®Biological: Actemra®
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 465
- Registration Number
- NCT06475508
- Locations
- 🇷🇺
Limited Liability Company "Family Clinic No. 4", Korolev, Moscow Region, Russian Federation
🇷🇺Limited Liability Company Research Medical Complex "Your Health", Kazan, Republic Of Tatarstan, Russian Federation
🇷🇺State health care institution city clinical hospital №25, Volgograd, Volgograd Region, Russian Federation
A Study of the Tolerance, Safety, and Pharmacokinetics of GNR-055 in Healthy Volunteers
- Conditions
- Mucopolysaccharidosis Type IIMetabolic Diseases
- Interventions
- Biological: verenafusp alfa 6 mg/kgBiological: verenafusp alfa 12 mg/kgBiological: verenafusp alfa 9 mg/kg
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 18
- Registration Number
- NCT06475404
- Locations
- 🇷🇺
State budgetary healthcare institution of the city of Moscow "City Clinic No. 2 of the Moscow Health Department", Moscow, Russian Federation
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
- Conditions
- ST Elevation Myocardial Infarction
- Interventions
- Biological: MetalyseBiological: GNR-060
- First Posted Date
- 2022-11-01
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- AO GENERIUM
- Target Recruit Count
- 244
- Registration Number
- NCT05601999
- Locations
- 🇷🇺
Regional State Budgetary Health Institution "Regional Clinical Emergency Hospital", Barnaul, Altai Territory, Russian Federation
🇷🇺Regional State Budgetary Institution of Health Care "Altai Territorial Cardiology Dispensary", Barnaul, Altai Territory, Russian Federation
🇷🇺State Budgetary Institution of Health Care of the Arkhangelsk Region "First City Clinical Hospital named after E.E. Volosevich", Arkhangel'sk, Arkhangelsk Region, Russian Federation